Amber Bennett

Amber specialises in the development and validation of complex ligand-binding and cell-based immunoassays to support clinical trials. This includes regulated PK, ADA, and nAb assessments, as well as Context-of-Use assays.

Her career at Synexa has consistently centered on addressing scientific challenges and delivering high-quality assays. She has trained and led Synexa’s soluble biomarker teams globally in advanced large molecule assessment techniques, including MSD, ELISA, and fluorescence- and luminescence-based platforms.

Earlier in her career, Amber worked as a Regulatory Affairs Officer, gaining extensive experience in regulatory compliance, license applications, and Drug Master File preparation. This experience has been instrumental in deepening her understanding of regulatory submission requirements.

Amber is passionate about bespoke scientific approaches and enjoys providing practical solutions for complex problems. She holds a Master of Science degree in Physiology from Stellenbosch University, with a focus on immunology and stress-induced inflammatory conditions.